Transgenic Group (TSE:2342) Debt-to-Asset : 0.25 (As of Sep. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Transgenic Group Debt-to-Asset?

Transgenic Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円1,536 Mil. Transgenic Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円1,140 Mil. Transgenic Group's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was 円10,575 Mil. Transgenic Group's debt to asset for the quarter that ended in Sep. 2024 was 0.25.

Transgenic Group Debt-to-Asset Historical Data

The historical data trend for Transgenic Group's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgenic Group Debt-to-Asset Chart

Transgenic Group Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Asset

Get a 7-Day Free Trial

0.23

0.22

0.17

0.23

Transgenic Group Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															0.23	0.23	0.26	0.23	0.25

Competitive Comparison of Transgenic Group's Debt-to-Asset

For the Biotechnology subindustry, Transgenic Group's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Transgenic Group's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transgenic Group's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Transgenic Group's Debt-to-Asset falls into.

Save Embed

;

Save Embed

;

Transgenic Group Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Transgenic Group's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(929.984	+	1327.076)	/	9810.999
	=	0.23

Transgenic Group's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1536.374	+	1139.878)	/	10575.344
	=	0.25

Transgenic Group (TSE:2342) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Transgenic Group Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Transgenic Group's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Transgenic Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgenic Group Inc (TSE:2342) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-7-1 Yurakucho, Yurakucho Denki Building South Wing 4th Floor, Chiyoda-ku, Kobe-shi, JPN, 100-0006

Website

http://www.transgenic.co.jp

Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals.

Transgenic Group Headlines

No Headlines